{
  "ticker": "LLY",
  "target_date": "2025-12-04",
  "actual_date": "2025-12-04",
  "collected_at": "2025-12-08T12:37:06.473028",
  "price": {
    "open": 1032.63,
    "high": 1032.63,
    "low": 1007.18,
    "close": 1014.489990234375,
    "volume": 3854900,
    "change_1d_pct": -1.85,
    "change_7d_pct": -5.2,
    "change_30d_pct": 25.05
  },
  "technicals": {
    "rsi_14": 48.31,
    "sma_20": 1029.54,
    "sma_50": 904.72,
    "macd": 44.155,
    "macd_signal": 54.72,
    "macd_histogram": -10.564,
    "bb_upper": 1126.85,
    "bb_lower": 932.22,
    "price_vs_sma20_pct": -1.46,
    "price_vs_sma50_pct": 12.13,
    "volume_ratio": 0.94
  },
  "fundamentals": {
    "market_cap": 891104919552,
    "pe_ratio": 48.703087,
    "forward_pe": 43.86717,
    "price_to_book": 37.42583,
    "price_to_sales": 14.996767,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.61,
    "pct_from_52w_low": 59.36
  },
  "macro": {
    "spy": {
      "price": 684.39,
      "change_1d_pct": 0.07,
      "change_7d_pct": 1.39
    },
    "vix": {
      "level": 15.78,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.11
    },
    "dollar_index": {
      "level": 98.99
    },
    "gold": {
      "price": 4211.8
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Avidity Biosciences, Inc. (RNA): A\u00a0Bull\u00a0Case Theory",
      "source": "Yahoo",
      "datetime": 1764874754,
      "summary": "We came across a bullish thesis on Avidity Biosciences, Inc. on BiotechBonanza\u2019s Substack by AnotherBio. In this article, we will summarize the bulls\u2019 thesis on RNA. Avidity Biosciences, Inc.\u2019s share was trading at $71.54 as of December 2nd. Novartis is acquiring Avidity RNA, a pre-Phase 3 biotech c",
      "url": "https://finnhub.io/api/news?id=a78f8266f6f1c008c18c5de7696a062fc21ee5f9bc926288ed8d80c29acfdc24"
    },
    {
      "headline": "Danaher Stock Earns Relative Strength Rating Upgrade",
      "source": "Yahoo",
      "datetime": 1764874414,
      "summary": "Danaher stock had its Relative Strength (RS) Rating upgraded from 68 to 72 Thursday \u2014 a welcome improvement, but still shy of the 80 or higher score you prefer to see. \u00a0  When To Sell Stocks To Lock In Profits And Minimize Losses  IBD's unique rating tracks market leadership with a 1 (worst) to 99 (",
      "url": "https://finnhub.io/api/news?id=c2a93c5717742cb3edc73aea773a0f25f113f3ad41222065647c8d75a4f57ba7"
    },
    {
      "headline": "Denmark's $600 Billion Economy Just Got a Boost--Thanks to One Drugmaker",
      "source": "Yahoo",
      "datetime": 1764874253,
      "summary": "Novo Nordisk's weight on GDP, jobs, and exports is reshaping Denmark's growth story despite layoffs and tariff headwinds.",
      "url": "https://finnhub.io/api/news?id=4c4d76a982ea8deecd0098b3f1a6f05dd3ad25975633d6bfd12754ff2aee2ef4"
    },
    {
      "headline": "Eli Lilly and Company (LLY): A\u00a0Bull\u00a0Case Theory",
      "source": "Yahoo",
      "datetime": 1764866657,
      "summary": "We came across a bullish thesis on Eli Lilly and Company on Pebble Bites\u2019s Substack by Christina Gan. In this article, we will summarize the bulls\u2019 thesis on LLY. Eli Lilly and Company\u2019s share was trading at $1,075.47 as of November 28th. LLY\u2019s trailing and forward P/E were 52.69 and 33.90, respecti",
      "url": "https://finnhub.io/api/news?id=afc5dfafea918081721b3c01c1dba828ec79c21758e041c9b2b7b85e5c52d43f"
    },
    {
      "headline": "LLY Trading Above 50 & 200-Day SMAs for 2 Months: How to Play the Stock",
      "source": "Yahoo",
      "datetime": 1764866520,
      "summary": "Lilly trades above key SMAs as strong GLP-1 demand, new drugs and pipeline momentum drive shares.",
      "url": "https://finnhub.io/api/news?id=25edc50f85cdd1f28a56ef8e6b0a6252cf3f4c8127c1fc693e0ee4b6feb3097b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}